Dmitry Balyasny’s Acutus Medical Inc AFIB Stock Holding History

Dmitry Balyasny’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-29,804	Closed	-$506K	–	2533
2021 Q2	$506K	Buy	+29,804	New	+$436K	﹤0.01%	1546

Other funds holding AFIB

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return

Dmitry Balyasny's AFIB Position: Q3 2021 in Review

Dmitry Balyasny sold out of Acutus Medical Inc (AFIB) in Q3 2021, closing a stake of 29,804 shares — an estimated $506K sold.

Dmitry Balyasny first reported a position in AFIB in Q2 2021 and held it in 1 quarter. The position peaked at $506K in Q2 2021. 70 funds tracked by Wall St. Rank hold AFIB as of Q3 2021.

Dmitry Balyasny reported no remaining Acutus Medical Inc position as of Q3 2021 after selling out during the quarter.
Dmitry Balyasny sold 29,804 Acutus Medical Inc shares in Q3 2021, an estimated $506K.
Dmitry Balyasny first reported a position in Acutus Medical Inc in Q2 2021 and held it in 1 quarter.
Dmitry Balyasny's Acutus Medical Inc position peaked at $506K in Q2 2021.
70 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.